Reading size

PACK IN HAND · ONE-PAGE CHECK

Medicine pack check sheet

Print this sheet or fill it in before speaking with a pharmacist or clinician. Copy only what is printed on the pack in hand. The published fields below are starting points from this record, not proof that your pack is the same product.

Published record starting point

Record display name
Lexapro
Generic name / active ingredient
escitalopram
Dosage-form class
Dosage form and presentation as documented in the linked primary label
Route
Oral
Record reviewed
2026-08-23

Copy from the pack in hand

Source-linked reading points

  • 5, 10 and 20 mg are labelled tablet strengths; 1 mg/mL is an oral-solution concentration. They are not the same type of label, do not support self-conversion from “tablets” to “millilitres,” and do not make products interchangeable because the generic name or a number looks similar.
  • This label lists scored 10 mg and 20 mg tablets and a non-scored 5 mg tablet. A score is appearance/formulation information in this exact label, not universal permission to split, combine, adjust or substitute any tablet; have the actual package checked by a pharmacist or prescribing team.
  • The public label notes discontinuation-related symptoms and calls for gradual rather than sudden handling. Do not abruptly self-stop, take it on alternating days, use someone else’s medicine or change to another antidepressant because of short-term mood, sleep, gastrointestinal symptoms, leftover medicine or online experience.
  • The label lists combination-risk clues involving other serotonin-affecting medicines, MAOIs, pain and migraine medicines, herbs and other products. Bring every prescription, OTC product, supplement and alcohol use together to a pharmacist or prescribing team; a webpage cannot determine individual combination or switching.

Reviewed presentation examples — compare every field

  • Escitalopram 5 mg per tablet; 100-tablet bottleNDC 0456-2005-01
  • Escitalopram 10 mg per tablet; 100-tablet bottleNDC 0456-2010-01
  • Escitalopram 20 mg per tablet; 100-tablet bottleNDC 0456-2020-01

EDITORIAL RECORD

Who prepared and checked this page

Byline
OriginDrug Content Editorial
Review role
Public primary-source verification
Last reviewed
2026-08-23
Source record
3 clickable primary-source entry points are listed with this dossier.

The review role checks source traceability, stated market, document version and product-identity fields. It is not a claim of clinical licensure, prescribing authority or individual pharmacy service. Read the editorial policy.

Search records
Enlarged public-label image